At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 125 enrolled
Drug / intervention
Vitamin C +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating Vitamin C in Septic Shock: A Randomized Double Blind Placebo Controlled Trial
In Brief
A Phase 3 clinical trial evaluating Vitamin C and Placebo for Septic Shock and Sepsis. Completed, enrolled 125 participants across 1 site.
Detailed Summary
This is a randomized, double-blind, placebo-controlled clinical trial to compare Vitamin C versus placebo for patients presenting to the ICU with a diagnosis of septic shock.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeptic Shock, Sepsis
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedNov 2017
Enrollment StartDec 2017
Primary CompletionJun 2020
Study CompletionAug 2020
TodayJul 2026
First PostedNov 9, 2017
Enrollment StartDec 20, 2017
Primary CompletionJun 30, 2020
Study CompletionAug 10, 2020
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 8.6 years ago
Interventions
Vitamin Cdrug
Continuous infusion of vitamin C
Placebodrug
Placebo designed to mimic intervention